Research, Lab and Study Groups of the Charité Comprehensive Cancer Center

We understand that early clinical trials are a crucial step in this process, which is why our focus is on conducting phase I clinical trials to evaluate drug tolerability.

The group focuses on the direct translation of molecular findings into personalized cancer therapy and a better understanding of tumor biology.

The research group consists of experts - ophthalmologists, internal medicine oncologists, interventional radiologists, radiation oncologists, diagnostic radiologists and scientists involved in uveal melanoma. It conducts basic research and clinical trials to improve therapy for this rare disease.

The Granada Lab develops theoretical and experimental methods that combine long-term live single-cell recordings with time series analysis, non-linear dynamics and mathematical modeling.

The Intercultural Communication Unit of the Charité Comprehensive Cancer Center represents a part of health services research that deals with cancer care for patients with a migration background.